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Introduction
This overview of solid organ transplantation in the United
States is produced as part of the 2009 OPTN/SRTR An-
nual Report. The Scientific Registry of Transplant Recipi-
ents (SRTR) prepares the Annual Report in collaboration
with the Organ Procurement and Transplantation Network
(OPTN) under contract with the Health Resources and Ser-
vices Administration (HRSA). The report contained herein
was prepared by the Arbor Research Collaborative for
Health, which, with the University of Michigan, is the con-
tractor for the SRTR.
This report reviews many aspects of solid organ transplan-
tation to provide a resource for patients, the transplant
community, the public and the federal government. It fea-
tures 10 articles showcasing specific topics in solid organ
transplantation. Experts in the field of transplantation con-
tributed to each article, offering a comprehensive look at
the current state of transplantation and trends over the
past decade.
Text and figures are drawn from recent SRTR analy-
ses and reference tables of the 2009 Annual Report.
Those reference tables may be accessed online at the
SRTR and OPTN websites (www.ustransplant.org and
optn.transplant.hrsa.gov), along with the articles presented
here.
Summary Statistics on Organ
Transplantation in the United States
At the close of 2007, 183 222 persons were recorded in
available OPTN data as living with a functioning trans-
planted organ [Table 1.14]. This reflects an increase of
1.7% over 2006 and a 56.6% increase since 1999.
The total number of organs transplanted decreased from
27 586 in 2007 to 27 281 in 2008. This was an overall
decrease of 305 organs transplanted (1.1%), including 91
(1.4%) fewer living donor transplants (Table 1). The num-
ber of deceased donor kidney transplants increased by
only 0.2%, while living donor kidney transplants dropped
by 1.2%. A decrease of 1.1% was observed in deceased
donor liver transplants in 2008. There was a corresponding
1.57% overall decrease in the number of organs recovered
for transplant during this time period (Table 2).
Table 3, which includes patients listed at both active and
inactive status, shows the 1-year change in the number of
patients on the waiting list for each organ. At the end of
2008, 100 597 people were registered on organ waiting
lists (67 470 active, 33 120 inactive and 7 of unknown
status). This reflects a 3.8% increase over the number of
people waiting for an organ at the end of 2007 [Table 1.4].
There were 25 465 patients listed as inactive status on
the kidney waiting list at the end of 2008. The percentage
of patients who were inactive on the kidney waiting list at
the end of each year has increased from 10% in 2003 to
33% in 2008 [Tables 5.1a and 5.1b]. This increase might
be largely attributed to policy implemented in 2003, which
allows accrual of waiting time during inactive status (http://
optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs
/policy_7.pdf. See policy 3.5.11.1) (1).
The kidney waiting list grew 6.3%, while the liver waiting
list decreased 3.4%, and the lung waiting list decreased
8.8%. The size of the waiting list is influenced by many
factors, including listing practices, donation rates, death
rates and allocation policy.
Patient survival after transplant is recognized as an im-
portant metric for evaluating transplantation success.
961
Wolfe et al.
Table 1: Change in number of transplanted organs, 2007–2008
Transplanted organs 2007 2008 % change
Total 27 586 27 281 −1.1
Deceased donor 21 279 21 065 −1.0
Living donor 6307 6216 −1.4
Kidney 16 120 16 067 −0.3
Deceased donor 10 082 10 101 0.2
Living donor 6038 5966 −1.2
Pancreas 1215 1161 −4.4
PTA 108 122 13.0
PAK 259 214 −17.4
Kidney–pancreas 848 825 −2.7
Liver 5890 5817 −1.2
Deceased donor 5629 5568 −1.1
Living donor 261 249 −4.6
Intestine (deceased donor) 57 69 21.1
Heart (deceased donor) 2143 2085 −2.7
Lung 1461 1473 0.8
Deceased donor 1458 1473 1.0
Living donor 3 – n/a
Heart–lung 31 26 −16.1
Source: 2009 OPTN/SRTR Annual Report, Table 1.7.
Table 4 shows the percentage of transplant recipients still
alive 1 and 5 years after transplantation, by organ. The
‘1-year survival’ cohort consists of recipients transplanted
in 2006–2007, while the ‘5-year survival’ cohort is based
on recipients transplanted in 2002–2005. These are the
most recent cohorts for which adequate follow-up data
are available. One-year patient survival was above 90%
for transplants involving deceased and living donor kidney
alone, kidney–heart, kidney–pancreas, pancreas after kid-
ney (PAK) and pancreas transplants alone (PTA). One-year
patient survival following kidney–liver transplant was lower
(87.4%). Patient survival was lowest for liver–intestine
transplants (63.3%), plausibly due to the greater burden of
disease for patients receiving the multi-organ transplant.
Table 5 shows graft survival by organ at 1 and 5 years af-
ter transplantation. Graft survival was calculated using the
same cohorts as patient survival (Table 4). Over 90% of
kidneys transplanted alone or in combination with other or-
gans were functioning 1 year after transplantation, except
for those used in kidney–liver and kidney–heart transplants,
of which 83% and 88% were still functioning after 1 year,
respectively. Some patients survived organ failure by re-
Table 2: Change in number of recovered organs, 2007–2008
Recovered organs 2007 2008 % change
Total 28 405 27 958 −1.57
Kidney 14 381 14 274 −0.74
Pancreas–all 1932 1830 −5.28
Liver 7025 6832 −2.75
Intestine 205 197 −3.90
Heart 2287 2226 −2.67
Lung 2575 2599 0.93
Source: 2009 OPTN/SRTR Annual Report, Table 1.2.
Table 3: Patients on waiting lists at end of year, 2007–2008
End of year % change
in total
Total % Total % (2007–
Organs 2007 inactive 2008 inactive 2008)
All organs 96 874 33 100 597 33 3.8
Kidney 71 601 32 76 089 33 6.3
PTA 581 59 581 64 0.0
PAK 919 75 856 74 −6.9
Kidney–
pancreas
2235 40 2234 45 0.0
Liver 16 365 25 15 807 23 −3.4
Intestine 220 24 212 31 −3.6
Heart 2637 47 2711 38 2.8
Lung 2211 55 2016 46 −8.8
Heart–lung 105 68 91 64 −13.3
Source: 2009 OPTN/SRTR Annual Report, Table 1.3, 5.1a-b, 6.1a-
b, 7.1a-b, 8.1a-b, 9.1a-b, 10.1a-b, 11.1a-b, 12.1a-b, 13.1a-b. PTA =
pancreas transplant alone. PAK = pancreas after kidney.
ceiving a subsequent transplant or alternative therapy such
as dialysis or resumption of insulin, resulting in lower graft
survival rates than corresponding patient survival rates.
Table 6 shows that posttransplant patient and graft sur-
vival outcomes have improved over the past decade for
almost every organ [Tables 1.11b and 1.12b]. Unadjusted
1-year graft survival for deceased donor kidney recipients
improved from 88.8% to 91.4%. Graft survival after liv-
ing donor kidney transplant improved 2%. Unadjusted 1-
year graft survival for deceased donor and living donor liver
recipients improved 6% and 16%, respectively. One-year
graft survival after intestine (alone) transplant increased
markedly from 50% in 1998 to 75% in 2007. The greatest
improvement was seen in heart-lung recipients, for whom
1-year unadjusted graft survival increased from 54% in
1998 to 90% in 2007. While only PTA transplants showed
Table 4: Unadjusted 1- and 5-year patient survival by organ
Organ 1-year survival 5-year survival
transplanted (Txp 2006–2007) (Txp 2002–2007)
Kidney
Deceased donor 95.6% 81.9%
Living donor 98.5% 91.0%
Pancreas alone 97.8% 88.7%
Pancreas after kidney 97.0% 84.5%
Kidney–pancreas 95.7% 87.2%
Liver
Deceased donor 88.4% 73.8%








Source: 2009 OPTN/SRTR Annual Report, Table 1.13.
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Table 5: Unadjusted 1- and 5-year graft survival by organ
Organ 1-year survival 5-year survival
transplanted (Txp 2006–2007) (Txp 2002–2007)
Kidney
Deceased donor 91.0% 69.3%
Living donor 96.3% 81.4%
Pancreas alone 75.5% 51.5%
Pancreas after kidney 80.0% 53.4%
Kidney–pancreas (kidney) 92.5% 78.6%
Kidney–pancreas (pancreas) 84.8% 73.4%
Liver
Deceased donor 84.3% 68.4%





Kidney–liver (kidney) 83.0% 64.4%
Kidney–liver (liver) 83.7% 66.0%
Kidney–heart (heart) 92.6% 76.0%
Kidney–heart (kidney) 88.2% 72.0%
Liver–intestine (intestine) 58.7% 53.0%
Liver–intestine (liver) 58.7% 53.4%
Source: 2009 OPTN/SRTR Annual Report, Table 1.13.
lower graft survival in 2007 than in 1998, the graft survival
estimates are based on small numbers of transplants and
are not statistically significantly different from each other
(p = 0.83). The statistical significance of each comparison
of 1998 survival with 2007 survival is shown in Table 6 by
organ type.
Trends in patient survival over the past decade have mir-
rored those in graft survival, with notable improvements
in survival for recipients of every organ type except PTA,
PAK and intestine. Trends in patient and graft survival
are explored in detail in each of the organ specific arti-
cles in this volume of the 2009 Report on the State of
Transplantation.
Transplantation at a Glance
The figure sets accompanying this article (Figures 1–8) pro-
vide overviews of the state of transplantation for eight or-
gan groups: kidney, PTA, PAK, liver, intestine, heart, lung
and simultaneous pancreas–kidney (SPK) transplantation,
which is the most common multi-organ procedure. Be-
cause of the small numbers of other multi-organ proce-
dures (e.g. heart–lung transplants), they are excluded from
the counts presented here.
Number of transplants and size of active waiting list
These figures show the size of the active waiting list and
the number of transplants performed for each of the past
10 years. The size of the waiting list is best described as a
snapshot capturing the number of candidates active on the
waiting list on December 31. It does not count those pa-








89% 91% 3 <0.0001
Kidney: living donor
graft survival
95% 97% 2 <0.0001
Pancreas transplant
alone
78% 76% −1 0.8341
Pancreas after
kidney
72% 82% 10 0.0302
Kidney–pancreas:
kidney
91% 93% 2 0.1355
Kidney–pancreas:
pancreas




80% 86% 6 <0.0001
Liver: living donor
graft survival
70% 87% 16 0.0022
Intestine 50% 75% 25 0.0004
Heart 85% 88% 3 0.0006
Lung 75% 80% 5 0.0115
Heart–lung 54% 90% 36 0.0001
Year of
transplant




95% 96% 1 0.0055
Kidney: living donor
patient survival
98% 99% 1 0.0015
Pancreas transplant
alone
98% 98% 0 0.9320
Pancreas after
kidney
94% 97% 3 0.2472




86% 89% 3 <0.0001
Liver: living donor
patient survival
80% 91% 11 0.0173
Intestine 67% 78% 11 0.0995
Heart 86% 89% 3 0.0006
Lung 77% 82% 6 0.0016
Heart–lung 57% 90% 34 0.0003
Source: 2009 OPTN/SRTR Annual Report, Table 1.11b, 1.12b.
tients who were transplanted, listed or removed during the
preceding 12 months. The number of transplants includes
all transplants performed over the year.
Because of these different methods of counting, for
some organs (e.g. lung), the number of transplants
performed during a certain year may exceed the number
of people awaiting a transplant on the last day of the same
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Figure 1: Kidney transplantation at a
glance. (A) Number of transplants and size
of active waiting list. There was a very
large gap between the number of patients
waiting for a transplant and the number
receiving a transplant. This gap widened
over the decade, meaning that the wait-
ing times from listing to transplant contin-
ued to increase. The number of living donor
transplants grew until 2004, while the num-
ber of deceased donor transplants contin-
ued to rise gradually until 2006. Source:
2009 OPTN/SRTR Annual Report, Tables
1.7, 5.1a. (B) Age distribution of recipients
and active waiting list. In 2008, older can-
didates (age >50 years) made up a much
larger fraction of patients actively awaiting
an organ than a decade earlier. The same
pattern was observed for transplant recipi-
ents. Source: 2009 OPTN/SRTR Annual Re-
port, Tables 5.1a, 5.4a, 5.4b, 5.4c. (C) Un-
adjusted Patient and Graft Survival. Five-
year patient survival percentages (based on
transplants during 2002–2007) and 10-year
patient survival (based on transplants during
1997–2007) were clearly higher for recipi-
ents of living donor organs than for those
of deceased donor organs. Similarly, living
donor organs had the highest 5- and 10-year
graft survival. Source: 2009 OPTN/SRTR An-
nual Report, Tables 5.10a, 5.10b, 5.10d,
5.14a, 5.14b, 5.14d.
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Figure 2: Pancreas transplantation
alone (PTA) at a glance. (A) Number of
transplants and size of active waiting list.
The number of patients on the waiting list
for a pancreas transplant alone decreased
after 2003 and has remained at pre-2001
levels. The number of PTA transplants per
year was relatively stable. Source: 2009
OPTN/SRTR Annual Report, Tables 1.7,
6.1a. (B) Age distribution of recipients
and active waiting list. For PTA, more
pediatric candidates were wait-listed and
more received a transplant in 2008 than
in 1999, although the absolute numbers
are small. At the same time, the fraction
of recipients over age 50 years grew.
Pediatric diabetic patients rarely have
kidney failure before age 18 years, but
they are candidates for PTA. Source:
2009 OPTN/SRTR Annual Report, Tables
6.1a, 6.4. (C) Unadjusted patient and graft
survival. The 5-year patient survival rate
for PTA transplants was 89%. Graft sur-
vival was considerably lower, especially
at 5 and 10 years posttransplant. Source:
2009 OPTN/SRTR Annual Report, Tables
6.10, 6.14.
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Figure 3: Pancreas after kidney (PAK)
transplantation at a glance. (A) Num-
ber of transplants and size of active wait-
ing list. The number of patients on the
waiting list for a PAK transplant has de-
creased since 2003. The number who
received a transplant has matched the
number of candidates each year since
2004. The number of PAK transplants
has decreased from its highest level
of the decade in 2004. Source: 2009
OPTN/SRTR Annual Report, Tables 1.7,
7.1a. (B) Age distribution of recipients and
active waiting list. For PAK, a higher pro-
portion of wait-listed and transplanted pa-
tients were over 50 years old in 2008 than
in 1999. At the same time, a smaller pro-
portion of candidates and recipients were
in the 18–34 year age group. (Since re-
cipients were mostly type 1 diabetics,
the ages below 18 and above 65 years
were virtually unrepresented.) Source:
2009 OPTN/SRTR Annual Report, Tables
7.1a, 7.4. (C) Unadjusted patient and graft
survival. For PAK transplants, patient sur-
vival was similar to that seen for simul-
taneous kidney–pancreas transplant re-
cipients. Five-year patient survival was
85%. Pancreas graft survival after PAK
was considerably lower. Source: 2009
OPTN/SRTR Annual Report, Tables 7.10,
7.14.
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Figure 4: Simultaneous pancreas–
kidney (SPK) transplantation at a
glance. (A) Number of transplants and
size of active waiting list. SPK ac-
counts for the majority of all pancreas
transplants. Numbers of this proce-
dure were stable over the decade.
The gap between the number of pa-
tients waiting for a transplant and
the number receiving a transplant
has dropped substantially since 2000.
Source: 2009 OPTN/SRTR Annual Re-
port, Tables 1.7, 8.1a. (B) Age distri-
bution of recipients and active wait-
ing list. For SPK transplantation, pa-
tients over age 50 years made up
greater fractions of both candidates
and recipients in 2007 than in 1998.
At the same time, smaller proportions
of candidates and recipients were in
the 18–34 year age group. (Since re-
cipients were mostly type 1 diabet-
ics, the ages below 18 and above 65
years were virtually unrepresented.)
Source: 2009 OPTN/SRTR Annual Re-
port, Tables 8.1a, 8.4. (C) Unadjusted
patient and graft survival. Patient sur-
vival has improved for SPK recipients
in recent years. Five- and 10-year pa-
tient survival was 87% and 71%, re-
spectively. Graft survival is shown sep-
arately for the pancreas graft and the
kidney graft of each SPK transplant.
Source: 2009 OPTN/SRTR Annual Re-
port, Tables 8.10, 8.14.
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Figure 5: Liver transplantation at a
glance. (A) Number of transplants and
size of active waiting list. The number
of patients awaiting a liver transplant
at year-end peaked in 2001; this is
clearly related to the introduction of
the MELD/PELD allocation system in
2002. The number who received a
deceased donor liver transplant has
gradually increased, reaching a peak in
2006. The gap between the numbers
of candidates and recipients has been
slowly shrinking since 2002. Source:
2009 OPTN/SRTR Annual Report,
Tables 1.7, 9.1a, 9.1b. (B) Age distribu-
tion of recipients and active waiting list.
The numbers of candidates and recip-
ients age 35–49 years remained fairly
constant over the decade, but the age
group’s proportion by both measures
declined. Recipients included trans-
plants from both living and deceased
donors. Source: 2009 OPTN/SRTR
Annual Report, Tables 9.1a, 9.4a, 9.4b.
(C) Unadjusted patient and graft survival.
Patient survival in recent years has been
improving for both deceased donors and
living donors, with 74% and 79% of
patients, respectively, alive 5 years
following transplantation. Patient sur-
vival was higher than graft survival
because of the opportunity for repeat
liver transplantation in the event of
graft failure. Source: 2009 OPTN/SRTR
Annual Report, Tables 9.10a, 9.10b,
9.14a and 9.14b.
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Figure 6: Intestine transplantation at
a glance. (A) Number of transplants and
size of active waiting list. The numbers of
patients on the intestine waiting list and
the number receiving a transplant both
more than doubled between 1999 and
2008 despite the fact that the number of
patients on the waiting list has declined
since 2006. Source: 2009 OPTN/SRTR
Annual Report, Tables 1.7, 10.1a. (B) Age
distribution of recipients and active wait-
ing list. About 77% of intestine candi-
dates were in the pediatric age group
in 1999 compared with 78% in 2008.
Adults made up a greater portion of re-
cipients than candidates. Source: 2009
OPTN/SRTR Annual Report, Tables 10.1a,
10.4. (C) Unadjusted patient and graft sur-
vival. One-year patient survival was 78%
in 2008. Survival at 5 years was 57%.
Graft survival was lower, since recipients
may receive parenteral alimentation or re-
transplantation after graft failure. Source:
2009 OPTN/SRTR Annual Report, Tables
10.10, 10.14.
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Figure 7: Heart transplantation at a
glance. (A) Number of transplants and
size of active waiting list. The number
of heart transplants has remained stable
over the past decade. The number of pa-
tients awaiting a heart decreased steeply
from 2000 to 2005, likely reflecting im-
provements in medical and surgical ther-
apy for end-stage heart failure. Source:
2009 OPTN/SRTR Annual Report, Tables
1.7, 11.1a. (B) Age distribution of recip-
ients and active waiting list. Trends in
the age distribution of wait-listed candi-
dates show that the proportions (and ab-
solute numbers) of patients younger than
35 and older than 64 years increased,
while the age group 35–64 years has de-
creased. The trend in transplant recip-
ient age showed a similar pattern, al-
though the ages below 35 years had
greater representation than on the wait-
ing list. Source: 2009 OPTN/SRTR An-
nual Report, Tables 11.1a, 11.4. (C) Un-
adjusted patient and graft survival. Patient
survival improved in recent years for heart
recipients. At 1, 5 and 10 years follow-
ing heart transplantation, 88%, 75% and
56% of patients, respectively, were alive.
Graft survival was very similar to patient
survival because very few patients re-
ceive a second heart transplant. Source:
2009 OPTN/SRTR Annual Report, Tables
11.10, 11.14.
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Figure 8: Lung transplantation at a
glance. (A) Number of transplants and size
of active waiting list. The number of lung
transplants has increased in the last 2 years.
The number of patients awaiting a trans-
plant dropped steeply in 2005 after a stable
pattern during the prior 6 years. This sharp
reduction is largely attributable to a major
change in allocation policy, which is now
based on medical urgency and calculated
transplant benefit rather than waiting time.
Source: 2009 OPTN/SRTR Annual Report,
Tables 1.7, 12.1a. (B) Age distribution of
recipients and active waiting list. The lung
waiting list showed a mixed trend in age
distribution, with increasing percentages of
candidates older than 50 years and decreas-
ing percentages younger than 18 years.
Candidates 18–49 years old showed a cor-
responding reduction in the percentage of
the waiting list. The pattern for transplant re-
cipients showed a similar increase for ages
50 years and above and a decrease in per-
centages for younger ages, including chil-
dren. Source: 2009 OPTN/SRTR Annual Re-
port, Tables 12.1a, 12.4a, 12.4b. (C) Unad-
justed patient and graft survival. Patient sur-
vival has been improving in recent years. At
1 year following deceased donor lung trans-
plantation, 84% of patients were alive. Graft
survival was very similar to patient survival
because very few lung retransplants are
performed. Source: 2009 OPTN/SRTR An-
nual Report, Tables 12.10a, 12.10b, 12.14a,
12.14b.
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year. The narrowing gap between waiting list size and num-
ber of transplants can be explained, in some cases, by
changes in allocation policy and wait-listing practices.
Unadjusted patient and graft survival
The summary figures show survival of transplant recipi-
ents (patient survival) and continued function of the trans-
planted organ (graft survival) at 3 months, 1 year, 5
years and 10 years following transplantation. These results
are based on analysis of the most recent cohorts, with
sufficient follow-up time for data collection and ascertain-
ment of events.
The Articles in the 2009 Report on the State
of Transplantation
This report first presents ‘Organ Donation and Utilization in
the United States, 1999–2008’ (2). Five organ-specific ar-
ticles then follow: ‘Kidney and Pancreas Transplantation in
the United States, 1999–2008: The Changing Face of Living
Donation’ (3), ‘Liver Transplantation in the United States,
1999–2008’ (4), ‘Intestine and Multi-Visceral Transplanta-
tion in the United States, 1999–2008’ (5), ‘Heart Transplan-
tation in the United States, 1999–2008’ (6) and ‘Lung Trans-
plantation in the United States, 1999–2008’ (7). Each piece
provides detailed updates regarding donation, waiting
time, allocation, posttransplant outcomes and the
demographics of candidates and recipients. These arti-
cles are intended to supplement the 2009 OPTN/SRTR
Annual Report coverage of 10-year trends, with reporting
on recent changes in allocation policy, clinical practice and
other areas relevant to the transplantation of different or-
gan types.
This year’s report concludes with three special-focus ar-
ticles that closely examine issues of recent interest to
the transplant community. ‘Geographic Variation in End-
Stage Renal Disease Incidence and Access to Kidney
Transplantation’ (8) investigates differences in organ do-
nation rates and how the density of end-stage renal
disease (ESRD) in the general population affects access
to the kidney transplant waiting list and successful kid-
ney transplantation. ‘DonorNet and the Effects on Organ
Donation’ (9) discusses the impact of DonorNet on organ
utilization, focusing on ischemia time of transplanted or-
gans and graft outcomes. ‘Transplant Outcomes Among
Minorities Between 1999 and 2008: Determinants of Kid-
ney Allograft Survival’ (10) assesses trends in minority ac-
cess to care and outcomes for kidney and heart transplan-
tation by race/ethnicity category, and examines specific
determinants of kidney transplant outcomes. Each article
includes special analyses conducted by the SRTR, address-
ing topics that are both timely and pertinent because of
their implications for policy and clinical practice.
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